December 2024 Provider Newsletter

Contents

AdministrativeCommercialDecember 1, 2024

Case Management program

AdministrativeMedicare AdvantageMedicaidDecember 1, 2024

Drug and biologic

AdministrativeCommercialDecember 1, 2024

PCP after‑hours access requirements

AdministrativeCommercialDecember 1, 2024

Coordination of care

AdministrativeCommercialDecember 1, 2024

Clinical practice and preventive health guidelines available online

AdministrativeCommercialDecember 1, 2024

Important information about utilization management

AdministrativeMedicare AdvantageNovember 18, 2024

Nevada 2025 Medicare Advantage plan changes

AdministrativeMedicare AdvantageNovember 15, 2024

Skilled nursing facility — vaccine serum compensation

AdministrativeCommercialMedicare AdvantageDecember 1, 2024

Quest Diagnostics joins our network on January 1

AdministrativeCommercialDecember 1, 2024

Members’ Rights and Responsibilities

Digital SolutionsCommercialMedicare AdvantageMedicaidNovember 14, 2024

Maximizing care with regular provider data attestation

Digital SolutionsMedicaidNovember 14, 2024

Advancing digital efficiency by discontinuing paper remittances

Digital SolutionsCommercialMedicare AdvantageMedicaidNovember 1, 2024

Roster Automation updates: roster download functionality

Behavioral HealthMedicaidNovember 11, 2024

Nevada expanded applied behavioral analysis services to all ages

Education & TrainingMedicare AdvantageNovember 18, 2024

Notice of change: Part D Rx HCCs

Policy UpdatesMedicaidNovember 15, 2024

Carelon Medical Benefits Management, Inc. updates

Policy UpdatesMedicare AdvantageOctober 30, 2024

Clinical Criteria updates

Policy UpdatesMedicaidNovember 7, 2024

Clinical Criteria update

Policy UpdatesMedicaidNovember 15, 2024

Clinical Criteria updates

Medical Policy & Clinical GuidelinesMedicaidNovember 14, 2024

Medical Policies and Clinical Utilization Management Guidelines update

Reimbursement PoliciesCommercialDecember 1, 2024

Material adverse change

Reimbursement policy update: Nurse Practitioner and Physician Assistant Services — Professional

Reimbursement PoliciesCommercialDecember 1, 2024

Material adverse change

New reimbursement policy: Trauma Activation — Facility

Products & ProgramsCommercialNovember 21, 2024

Expansion of Carelon Medical Benefits Management, Inc. programs

Federal Employee Program (FEP)CommercialDecember 1, 2024

FEP excited to join PSHB program in 2025

PharmacyCommercialNovember 18, 2024

Material adverse change

Specialty pharmacy updates — December 2024

PharmacyCommercialDecember 1, 2024

Pharmacy information available online

PharmacyCommercialDecember 1, 2024

Kroger Specialty Pharmacy acquisition

NVBCBS-CDCRCM-072824-24

AdministrativeCommercialDecember 1, 2024

Case Management program

Managing any illness can be challenging. Knowing who to contact, what test results mean, and how to access needed resources is important but can be overwhelming.

We are available to help with our case management program. Our case managers are part of an interdisciplinary team of clinicians and professionals who support members, families, primary care physicians, behavioral health practitioners, and caregivers. The case management process utilizes the experience and expertise of the care coordination team, whose goal is to educate and empower our members to increase their self-management skills, understand their illness, and learn about care choices to access quality, efficient healthcare.

Members or caregivers can refer themselves or family members for physical health services by calling the number below. They will be transferred to a team member based on the immediate need. Physicians can also refer by contacting us telephonically or through electronic means. No issue is too big or too small. We can help with transitions across levels of care so that patients and caregivers are better prepared and informed about healthcare decisions and goals. This voluntary program is private and offered at no cost to our members. They can opt out anytime if they change their mind about participating in the program.

For behavioral health or substance use disorder services, members can contact their health plan to verify benefits and access at Anthem.com or if they are Federal Employee Program (FEP) members, https://www.fepblue.org/ to search for and access behavioral health providers. To ensure privacy, having the member or member’s family contact our department directly is best.

How do you contact us?

The member can contact customer service for assistance for commercial and exchange members.

For FEP members, physical and behavioral health practitioners can refer to our behavioral health case management by calling 800‑711-2225, option 3, with member consent.

We are committed to helping patients more easily access the care they need.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CM-072594-24-CPN70347

AdministrativeMedicare AdvantageMedicaidDecember 1, 2024

Drug and biologic

Effective March 1, 2025, Anthem is enhancing its claim edits system to ensure claims billed with pharmaceutical drug procedure codes are reported with the appropriate FDA-approved indicators for on- and off-label use.

These enhanced claim edits provide an opportunity for Anthem to evaluate submitted claims for drug quality, safety, and effectiveness. The enhancement is to have the claims deny if not billed with FDA indicator for on/off label use.

If you believe a claim reimbursement decision should be reviewed, please follow the normal claims dispute process outlined in the provider manual and include medical records that clarify whether the indication was approved through the governing agencies. You will need to submit only the portion(s) of the medical record that is relevant to the drug provided.

If you have questions about this notification, contact your contract manager or provider relationship management account representative.

Anthem Blue Cross and Blue Shield Healthcare Solutions is the trade name of Community Care Health Plan of Nevada, Inc. Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CDCR-063024-24-CPN62565

AdministrativeCommercialDecember 1, 2024

PCP after‑hours access requirements

We are dedicated to ensuring compliance with NCQA accessibility standards by providing members with phone access to their PCPs beyond regular business hours. The annual after‑hours access study assesses adequate phone messaging for our members with perceived emergencies or urgent situations after office hours. Most of our plans measured still fall short of the after‑hours access expectations that patients have phone access to their practitioners 24 hours a day, 7 days a week, 365 days a year.

The current after‑hours messaging requirement is: When a patient calls after hours, a live person directs them to the practitioner or the on‑call practitioner, or a recording or live person directs the patient to an urgent care center, 911, or the ER.

If a patient reaches a practitioner’s voicemail, compliant messaging is imperative to assist the patient in gaining access to appropriate care.

We continue to work towards identifying simplified ways to access care.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-072073-24-CPN70346

AdministrativeCommercialDecember 1, 2024

Coordination of care

Coordination of care among providers is vital to good treatment planning and ensures appropriate diagnosis, treatment, and referral. We want to take this opportunity to stress the importance of communicating with your patients’ other healthcare practitioners, including PCPs/PMPs, medical specialists, and behavioral health practitioners.

Coordination of care is essential for patients who use general medical services extensively and those referred to a behavioral health specialist by another healthcare practitioner. We urge all our practitioners to obtain the appropriate permission from these patients to coordinate care between behavioral health and other healthcare practitioners when treatment begins.

We expect all healthcare practitioners to:

  1. Discuss with the patient the importance of communicating with other treating practitioners.
  2. Obtain a signed release from the patient and file a copy in the medical record.
  3. Document in the medical record if the patient refuses to sign a release.
  4. Document in the medical record if you request a consultation.
  5. If you make a referral, transmit the necessary information; if you furnish a referral, report appropriate information to the referring practitioner.
  6. Document evidence of clinical feedback (for example, a consultation report) that includes, but is not limited to:
    • Diagnosis
    • Treatment plan
    • Referrals
    • Psychopharmacological medication (as applicable)

To facilitate coordination of care, we have several tools available at https://www.Anthem.com/provider/forms/ for behavioral health and other medical practitioners, including:

  • Coordination of Care Form
  • Coordination of Care Letter Template — Behavioral Health
  • Coordination of Care Letter Template — Medical
  • Resources for provider collaboration and integrated care, including Practice Guidelines, assessment tools, suicide awareness, and multicultural education and guidance

The following behavioral health forms, brochures, and screening tools for substance use disorder and attention‑deficit/hyperactivity disorder (ADHD) are also available at https://www.Anthem.com/provider/forms/:

  • Alcohol use assessment brochure
  • Antidepressant medication management
  • Edinburgh Postnatal Depression Scale
  • Opioid use assessment brochure
  • Substance Brief Intervention/Referral Tool (SBIRT)
  • Vanderbilt ADHD Diagnostic Parent Rating Scale

We are committed to finding solutions that help our care provider partners offer quality services to our members.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-072071-24-CPN70343

AdministrativeCommercialDecember 1, 2024

Clinical practice and preventive health guidelines available online

As part of our commitment to provide you with the latest clinical information and educational materials, we have adopted nationally recognized medical, behavioral health, and preventive health guidelines, which are available to care providers on our website. The guidelines, which are used for our quality programs, are based on reasonable, medical evidence and are reviewed for content accuracy, current primary sources, the newest technological advances, and recent medical research.

All guidelines are reviewed annually and updated as needed. The current guidelines are available on our website at Anthem.com under For Providers. Select Policies, Guidelines & Manuals under Provider Resources. Select your state, then scroll down and select Clinical Practice Guidelines or Preventive Health Guidelines.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-072074-24-CPN70345

AdministrativeCommercialDecember 1, 2024

Important information about utilization management

Our utilization management (UM) decisions are based on the appropriateness of care and service needed, as well as the member’s coverage according to their health plan. We do not reward providers or other individuals for issuing denials of coverage, service, or care. Nor do we make decisions about hiring, promoting, or terminating these individuals based on the idea or thought that they will deny benefits. In addition, we do not offer financial incentives for UM decision makers to encourage decisions resulting in under-utilization. Anthem medical policies are available at Anthem.com.

You can also request a free copy of our UM criteria from our medical management department, and each treating provider directly involved in the member’s care may discuss a UM denial decision with a physician reviewer by calling us at the toll-free number listed on the UM denial letter, if they haven’t already done so, and before all applicable appeals are completed. UM criteria are also available on the web. Go to Anthem.com and select For Providers > Provider Resources > Policies, Guidelines and Manuals > Select your state > View Medical Policies & Clinical UM Guidelines.

We work with providers to answer questions about the utilization management process and the authorization of care. Here’s how the process works:

  • Call us toll-free from 8:30 a.m. to 5 p.m. Monday through Friday (except on holidays). More hours may be available in your area. Federal Employee Program (FEP) hours are 8 a.m. to 7 p.m. ET.
  • If you call after normal business hours, you can leave a private message with your contact information. Our staff will return your call on the next business day. Calls received after midnight will be returned the same business day.
  • Our associates will contact you about your UM inquiries during business hours, unless otherwise agreed upon.

The following phone lines are for physicians and their staff. Members should call the customer service number on their health plan ID card.

To discuss UM process and authorizations

To discuss
peer-to-peer UM denials with physicians

To request UM criteria

TDD/TTY

Business hours

800-336-7767

Transplant:

888-574-7215

National Transplant:

844-644-8101

866-536-7612

Behavioral Health:

800-228-5975

Autism:

Call customer service number on the back of the member’s ID card.

FEP:

800-860-2156

Local:

303-764-7227

Behavioral Health:

800-228-5975

Adaptive Behavioral Treatment:

Call customer service number on back of member’s ID card

FEP:

800-860-2156

800-797-7758

Providers: Leave message with provider name, provider phone number, member’s name, member ID, and reference number.

FEP:

800-860-2156

711

or

TTY/ASCII/HCO:
800-326-6868

Voice:

800-326-6888

Call us toll-free from 8:30 a.m. to 5 p.m. Monday through Friday (except on holidays). More hours may be available in your area. Federal Employee Program hours are 8 a.m. to 7 p.m. ET.

For language assistance, members can call the customer service phone number on the back of their ID card and a representative will be able to assist them.

Our utilization management associates identify themselves to all callers by first name, title, and company name when making or returning calls. They can inform you about specific utilization management requirements and operational review procedures and discuss utilization management decisions with you.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CM-072614-24

AdministrativeMedicare AdvantageNovember 18, 2024

Nevada 2025 Medicare Advantage plan changes

Annual benefit changes for Medicare Advantage plan members under Anthem Blue Cross and Blue Shield will be effective January 1, 2025.

Refer to attachment to view full details.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CR-069486-24-CPN69435

ATTACHMENTS (available on web): Nevada 2025 Medicare Advantage plan changes (pdf - 0.15mb)

AdministrativeMedicare AdvantageNovember 15, 2024

Skilled nursing facility — vaccine serum compensation

Skilled nursing facilities (SNF) compensated based on the prospective payment system for outpatient Medicare Advantage claims may see a change in vaccine serum reimbursement. Beginning March 1, 2025, Part B‑covered vaccines will be reimbursed based on the CMS‑published vaccine serum rates.

We are committed to helping patients more easily access the care they need.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-070574-24

AdministrativeCommercialMedicare AdvantageDecember 1, 2024

Quest Diagnostics joins our network on January 1

We’re always working to improve access to healthcare and bring more cost savings to our members. That’s why we’re excited to announce that Quest Diagnostics is joining our networks in Nevada on January 1, 2025.

Broader access for members and more options for providers

Adding Quest to our network will increase access to high-quality lab services with lower costs for members while also adding more options for providers. We’re lifting our exclusive arrangement with LabCorp for our Nevada commercial and Medicare Advantage plans. More options make it easier for members to find a conveniently located lab.

A full-service lab

Quest Diagnostics offers a wide range of services, including:

  • Routine medical tests
  • Advanced diagnostics
  • A strong pathologist network

For more information on our collaboration with Quest Diagnostics in Nevada, read our press release here.

We are committed to finding solutions that help our care provider partners offer quality services to our members.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CRCM-072576-24

AdministrativeCommercialDecember 1, 2024

Members’ Rights and Responsibilities

The delivery of quality healthcare requires cooperation between patients, their providers, and their healthcare benefit plans. One of the first steps is for patients and providers to understand their rights and responsibilities. Therefore, in line with our commitment to involve the health plan, participating practitioners, and members in our system, Anthem has adopted a Members’ Rights and Responsibilities statement.

The statement can be found on our website on the FAQ page. To access it, go to Anthem.com and select For Providers. From there, select Policies, Guidelines & Manuals under Provider Resources. Select your state and scroll down to Member Rights and Responsibilities under More Resources. Select the Read about member rights link. Then, under Laws and Rights that Protect You, select the question that says What are my rights as a member?

Practitioners may access the Federal Employee Plan (FEP) member portal at fepblue.org/memberrights to view the FEP Member Rights and Responsibilities statement.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-072072-24-CPN70344

Digital SolutionsCommercialMedicare AdvantageMedicaidNovember 14, 2024

Maximizing care with regular provider data attestation

At a glance:

  • Last month, we published information about the Consolidated Appropriations Act (CAA) data attestation process for Commercial providers here. This article provides additional information for Commercial, Medicaid, and Medicare Advantage providers about updating your provider data with us.
  • Care providers contracted with us will need to verify and update their demographic data every 90 days using the Provider Data Management (PDM) capability on Availity Essentials for efficient claims processing and timely reimbursement.
  • Updating and attesting data are critical for maintaining accurate service directories for members and non-compliance with these requirements can result in removal from the online provider directory.
  • Availity Essentials not only allows for data attestation but also provides digital applications that enable users to monitor submitted demographic updates in real time, review the history of previously verified data, and manage multiple updates within one spreadsheet via the Upload Roster feature.

What are the requirements for the attestation of demographic data?

We require our contracted care provider partners to attest to their demographic data every 90 days. Maintaining your provider data is critical as it results in improved connection to members seeking care, supports the accuracy of claims processing, and allows for timely reimbursement, while aligning to a bold purpose of improving the health of humanity.

How do I update and attest to my data?

We require the use of the PDM capability available on Availity Essentials to update your provider or facility data. There are two options within Availity Essentials PDM that are available at no cost to care providers:

  • Multi-payer platform, which includes Directory Verification and Core PDM: allows care providers to make required updates using Directory Verification and changes using Core PDM
  • Roster upload: allows care providers to submit multiple updates within one spreadsheet via the Upload Roster feature (the Upload Roster feature is currently only available and shared with the health plan)

Both the multi-payer platform and Roster Upload feature satisfy your 90-day attestation requirement.

To attest to your provider data:

  1. Log in to Availity Essentials.
  2. Navigate to My Providers > Provider Data Management.
  3. Select the action menu next to the business whose information you want to verify.
  4. Select Verify Directory Listing.
  5. Review each set of data for accuracy.
  6. Once complete, select Submit Verified Profile.

Organizations with no changes since their last submission may see a Quick Verify button that allows for directory verification in one click.

Individuals registered for their TIN within the Availity Manage My Organization application on Availity Essentials will receive periodic automated emails and notifications in the Notification Center on Availity reminding them when their attestation is due or overdue.

How do I access Availity Essentials and the PDM application?

To access the PDM application, log on to https://Availity.com and select My Providers > Provider Data Management to begin using PDM. Administrators will automatically be granted access to PDM. Additional staff may be given access to PDM by an administrator. To find your administrator, go to My Account Dashboard > My Account > Organization(s) > Administrator Information.

Within PDM you also have the ability to:

  • Monitor submitted demographic updates in real time with a digital dashboard.
  • Review the history of previously verified data.

Why is updating and attesting to my data important?

Our members use Find Care to make informed decisions about their healthcare and find quality doctors and hospitals. Keeping your data up to date ensures members have access to you when they need it the most.

Failure to complete the 90-day attestation requirement puts your organization at risk of being classified as non-compliant with the health plan’s policies and procedures and may result in removal from the online provider directory.

What if I’m not registered for Availity yet?

If you aren’t registered to use Availity Essentials, signing up is easy and secure. There is no cost to register or to use any of the digital applications. Start by going to https://Availity.com and selecting New to Availity? Get Started at the top of the home screen to access the registration page. If you have more than one TIN, ensure you have registered all TINs associated with your account.

If you have questions regarding registration, reach out to Availity Client Services at 800-AVAILITY (282-4548).

How do I get training on the Availity PDM tool?

You can learn about and attend one of our training opportunities by visiting here:

  • For more information on Availity PDM, check out the Quick Start Guide here using your Availity Essentials user ID and password.
  • For more information about the Roster Upload process:
    • See the Roster Submission Guide on https://Availity.com > Payer Spaces > Select Payer Tile > Resources > Roster Submission Guide using PDM.
    • Find training specifically for the Standard Template and Rules of Engagement by listening to our recorded webinar here.
    • Take an on-demand class hosted by Availity to learn about Provider Data Management here.

What if I’m a behavioral health care provider?

If you are a behavioral health care provider and assigned to Carelon Behavioral Health, Inc., follow the Carelon Behavioral Health process for attestation. Council for Affordable Quality Healthcare (CAQH) care providers should attest, confirm, or update their data through the CAQH website. Non-CAQH care providers and facilities should attest, confirm, or update their data directly with Carelon Behavioral Health.

Contact us

Availity Chat with Payer is available during normal business hours. Get answers to your questions about eligibility, benefits, authorizations, claims status, and more. To access Availity Essentials, go to https://Availity.com and select the appropriate Payer Spaces tile from the drop-down. Then, select Chat with Payer and complete the pre-chat form to start your chat.

We are committed to finding solutions that help our care provider partners offer quality services to our members. For additional support, visit the Contact Us section of our provider website for the appropriate contact.

Carelon Behavioral Health, Inc. is an independent company providing utilization management services on behalf of the health plan.

Anthem Blue Cross and Blue Shield Healthcare Solutions is the trade name of Community Care Health Plan of Nevada, Inc. Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CDCRCM-065686-24-CPN65572

Digital SolutionsMedicaidNovember 14, 2024

Advancing digital efficiency by discontinuing paper remittances

To advance our operations towards a more digitally efficient model, when a care provider registers for electronic remittance advice (ERA/835), we will cease issuing paper remittances 30 days after the effective registration date. Care providers will receive their remittance electronically through ERA with the option to print copies via Availity Essentials as needed in the Remit Inquiry application located in Payer Spaces.

Some care providers, despite successful registration, continue to receive remittances in both electronic and paper formats. We are actively addressing this redundancy by discontinuing the issuance of printed remittances. As a result, care providers who have enrolled for ERA/835 but are still receiving paper remittances began noticing a decrease in these paper transactions starting in late August.

If you have yet to register for ERA and wish to switch to electronic remittance reception, we recommend that you configure your ERA settings through Availity Essentials or by working with your existing clearinghouse vendor. In the interests of facilitating electronic transactions, care providers interested in receiving electronic payments are encouraged to visit the EnrollSafe Enrollment Hub (payeehub.org).

This transition is part of our ongoing commitment to streamlining our procedures, enhancing customer experience, and promoting environmental sustainability.

Anthem Blue Cross and Blue Shield Healthcare Solutions is the trade name of Community Care Health Plan of Nevada, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CD-065341-24-CPN65174

Digital SolutionsCommercialMedicare AdvantageMedicaidNovember 1, 2024

Roster Automation updates: roster download functionality

Background:

  • Care providers can request and download a full roster for an organization and TIN.
  • To request a roster, care providers must go to Payer Spaces in Availity Essentials as detailed below. This functionality is not on the Upload Roster File screen, which is where care providers upload rosters for processing.
  • After downloading the roster, care providers can use it to easily edit demographic information.

My Roster: request and download a copy of your current roster

Care providers can now download a copy of their full roster in Availity Essentials. This enhancement allows care providers to view and verify the demographic information we maintain and currently have loaded in our system.

To request a roster, go to Availity.com > Payer Spaces > Select Payer Tile > Provider Enrollment and Network Management > Request Current Roster.

Care providers will be prompted to select the organization name and TIN they would like included in the roster. Multiple TINs can be included in one request.

Download requested roster

The roster available for download from Payer Spaces in Availity Essentials will contain a few more columns than the standard template. The additional columns have drop-down menus that enable care providers to indicate what data needs to be updated and how (for example, updates or terminations).*

Care providers can edit the downloaded roster and upload the updated version via Availity’s Upload Roster File screen to easily make changes to their data. Because the download is correctly formatted, it should enable automatic processing.

* New group/professional contract requests and care provider additions to an existing group/professional contract must be submitted through the Provider Enrollment application in Availity Essentials.

As a reminder, care providers are responsible for the accuracy of the data they submit as well as submitting updates timely. If updates are not submitted timely and result in claim denials or rejections, those denials will stand.

Contact us
Availity Chat with Payer is available during normal business hours. Get answers to your questions about eligibility, benefits, authorizations, claims status, and more. To access Availity Essentials, go to Availity.com and select the appropriate payer space tile from the drop-down. Then, select Chat with Payer and complete the pre-chat form to start your chat.

For additional support, visit the Contact Us section of our provider website for the appropriate contact.

Anthem Blue Cross and Blue Shield Healthcare Solutions is the trade name of Community Care Health Plan of Nevada, Inc. Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CDCRCM-070208-24-CPN70176

Behavioral HealthMedicaidNovember 11, 2024

Nevada expanded applied behavioral analysis services to all ages

At a glance:

  • Senate Bill 191 removed all age limits for recipients of applied behavioral analysis (ABA) services.
  • All procedure codes billable by Provider Type 85 have been updated in the Medicaid Management Information System (MMIS) to reflect this change.
  • Prior authorization requirements remain unchanged, but Anthem is transitioning to the Availity Essentials Authorization app to streamline the process.

During the 2023 Nevada Legislative Session, Senate Bill 191 was passed, removing all age limits on recipients receiving ABA services.

Per this requirement, the following update was effective on or after April 1, 2024:

  • All procedure codes billable by provider type (PT) 85 (applied behavioral analysis) have been updated in the MMIS to allow recipients of any age to receive ABA services, so long as those members meet medical necessity criteria.

This applies to:

  • Members who meet all the required criteria under the Nevada Medicaid Services Manual for ABA services (MSM Chapter 3700).

This applies to the following provider types:

  • Provider Type 85

This applies to the following procedure codes:

  • 97151
  • 97152
  • 0362T
  • 97153
  • 97154
  • 97155
  • 97156
  • 97157
  • 97158
  • 0373T

or

  • All procedure codes billable by provider type (PT) 85 (Applied Behavioral Analysis)

The following update does not change the procedure for obtaining authorization for ABA services, and providers should continue to submit ABA requests following the current utilization management process.

Provider guidance for submitting authorization requests

The following links will provide support in our authorization processes:

Availity

Anthem is transitioning to the Availity Essentials Authorization application. You may already be familiar with the Availity Essentials multi-payer Authorization app because thousands of providers are already using it for submitting prior authorizations for other payers. We are eager to make it available to our providers, too.

Interactive care reviewer (ICR) is still available.

If you need to refer to an authorization submitted through ICR, you will still have access to that information. We’ve developed a pathway to access your ICR dashboard. You will simply follow the prompts provided through the Availity Essentials Authorization app. To make it even more convenient, you can pin your authorizations from the ICR application to your Availity Essentials Authorization app dashboard.

Innovation in process

While we grow the Availity Essentials Authorization app to provide you with Anthem-specific information, you may still need to access ICR for:

  • Appeals.
  • Behavioral health authorizations and inquiries.
  • Federal Employee Program® authorizations and inquiries.

Notices in the Availity Essentials Authorization app will guide you through the process for accessing ICR for alternate authorization and appeals functions.

Training is available

If you aren’t already familiar with the Availity Essentials Authorization app, training is available. Visit the Digital Solutions Learning Hub to access on-demand training, recorded webinars, and other training resources.

Now, give it a try

Accessing the Availity Essentials Authorization app is easy. Ask your organization’s Availity Essentials administrator to ensure you have the Authorization role assignment. Without the role assignment, you will not be able to access the Authorization application. Then, log onto https://Availity.com to access the app through the Patient Registration tab by selecting Authorizations and Referrals.

If you have questions about this communication or need assistance with any other item, contact your local provider relationship management representative or call Provider Services at 844-396-2330.

To join the network, visit: carelonbehavioralhealth.com/providers/join-our-network.

If you have questions, contact Carelon Behavioral Health, Inc. via email at provider.inquiry@carelon.com or through their website.

Note: Prior authorization requests for certain services may require additional documentation to determine medical necessity.

Carelon Behavioral Health, Inc. is an independent company providing utilization management services on behalf of the health plan.

Anthem Blue Cross and Blue Shield Healthcare Solutions is the trade name of Community Care Health Plan of Nevada, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CD-070853-24

Education & TrainingMedicare AdvantageNovember 18, 2024

Notice of change: Part D Rx HCCs

The Inflation Reduction Act and its impact on Part D Rx HCC model for 2025

On August 16, 2023, President Biden signed the Inflation Reduction Act (IRA) into law. This act brought about crucial reforms in the U.S. healthcare system, specifically impacting Medicare Advantage and Medicare Part D programs.

Starting January 1, 2025, the Part D Rx Hierarchical Condition Categories (HCC) risk adjustment (RA) model will undergo significant updates, reflecting the redesigned Part D benefits mandated by the IRA. This Medicare model helps categorize beneficiaries based on their overall health status and expected prescription drug costs. It will use diagnosis and drug utilization data to help predict healthcare costs associated with managing chronic conditions such as hypertension, COPD, and depression.

As part of the Part D Rx HCC model, it is essential for clinicians to thoroughly assess their patients’ active chronic conditions for presence or absence during each encounter and at least once each year. By maintaining comprehensive, accurate, and complete documentation during patient visits and coding to the highest level of specificity, providers can significantly enhance:

  • Submission of accurate and complete clinical documentation, coding, and data,
  • Appropriate resources to support effective management of costs,
  • Quality of patient care, and
  • Adherence to compliance regulations.

Thank you for your attention to these important updates. As clinicians, your commitment to accurate and complete documentation and compliant coding practices is essential. Together, we can navigate these changes and support the ongoing delivery of quality patient care.

If you have any RA Part D Rx HCC questions, please contact your Provider Success point of contact to coordinate efforts with the Enterprise Risk Adjustment team. For more detailed Part D model information, please visit the CMS website by clicking this link.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-072496-24-CPN72404

Policy UpdatesMedicaidNovember 15, 2024

Carelon Medical Benefits Management, Inc. updates

Effective December 18, 2024

Effective on December 18, 2024, the following Carelon Medical Benefits Management Clinical Appropriateness Guideline updates will be adopted for Anthem. This article is to communicate the plan adoption of these Carelon Medical Benefits Management guidelines. Existing prior authorization requirements have not changed. In the event a prior authorization requirement or site of care review requirement for these services will be implemented, a separate notice will be distributed before the addition of any such prior authorization or site of care review requirement.

You may access and download a copy of the current and upcoming guidelines here:

    • Cardiovascular:
      • Implantable Cardioverter Defibrillators
    • Genetic Testing:
      • Cell-free DNA Testing for the Management of Cancer
      • Prenatal Testing using cell-free DNA
      • Somatic Tumor Testing
    • Musculoskeletal:
      • Joint Surgery
      • Small Joint Surgery
    • Site of Care:
      • Site of Care for Advanced Imaging
      • Rehabilitative Site of Care
      • Surgical Site of Care

The above guideline updates have a publish date of November 17, 2024.

Please share this notice with other members of your practice and office staff.

Anthem Blue Cross and Blue Shield Healthcare Solutions is the trade name of Community Care Health Plan of Nevada, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CD-067233-24-CPN66675

Policy UpdatesMedicare AdvantageOctober 30, 2024

Clinical Criteria updates

Effective December 2, 2024

Summary: On August 16, 2024, the Pharmacy and Therapeutic (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem. These policies were developed, revised, or reviewed to support clinical coding edits.

Visit Clinical Criteria to search for specific policies. For questions or additional information, use this email.

Please see the explanation/definition for each category of Clinical Criteria below:

  • New: newly published criteria
  • Revised: addition or removal of medical necessity requirements, new document number
  • Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive

Please share this notice with other members of your practice and office staff.

Please note:

  • The Clinical Criteria listed below applies only to the medical drug benefits contained within the member’s medical policy. This does not apply to pharmacy services.
  • This notice is meant to inform the provider of new or revised criteria that has been adopted by Anthem only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.

Effective date

Clinical Criteria number

Clinical Criteria title

New or revised

December 2, 2024

*CC-0266

Rytelo (imetelstat)

New

December 2, 2024

CC-0156

Reblozyl (luspatercept)

Revised

December 2, 2024

CC-0244

Columvi (glofitamab-gxbm)

Revised

December 2, 2024

CC-0124

Keytruda (pembrolizumab)

Revised

December 2, 2024

CC-0104

Levoleucovorin Agents

Revised

December 2, 2024

CC-0182

Iron Agents

Revised

December 2, 2024

CC-0197

Jemperli (dostarlimab-gxly)

Revised

December 2, 2024

CC-0247

Beyfortus (nirsevimab)

Revised

December 2, 2024

*CC-0007

Synagis (palivizumab)

Revised

December 2, 2024

*CC-0082

Onpattro (patisiran)

Revised

December 2, 2024

*CC-0217

Amvuttra (vulrisiran)

Revised

December 2, 2024

*CC-0084

Tegsedi (inotersen)

Revised

December 2, 2024

*CC-0010

Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Inhibitors

Revised

December 2, 2024

CC-0209

Leqvio (inclisiran)

Revised

December 2, 2024

*CC-0193

Evkeeza (evinacumab)

Revised

December 2, 2024

*CC-0027

Denosumab

Revised

December 2, 2024

CC-0019

Zoledronic Acid

Revised

December 2, 2024

CC-0208

Adbry (tralokinumab)

Revised

December 2, 2024

*CC-0029

Dupixent (dupilumab)

Revised

December 2, 2024

*CC-0246

Rystiggo (rozanolixizumab-noli)

Revised

December 2, 2024

*CC-0207

Vyvgart (efgartigimod alfa-fcab) and Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-gvfc)

Revised

December 2, 2024

*CC-0028

Benlysta (belimumab)

Revised

December 2, 2024

*CC-0194

Cabenuva (cabotegravir extended-release; rilpivirine extended -release) injection

Revised

December 2, 2024

*CC-0002

Colony Stimulating Factor Agents

Revised

December 2, 2024

CC-0127

Darzalex (daratumumab) and Darzalex Faspro (daratumumab and hyaluronidase-fihj)

Revised

December 2, 2024

CC-0121

Gazyva (obinutuzumab)

Revised

December 2, 2024

CC-0242

Epkinly (epcoritamab-bysp)

Revised

December 2, 2024

CC-0130

Imfinzi (durvalumab)

Revised

December 2, 2024

CC-0158

Enhertu (fam-trastuzumab deruxtecan-nxki)

Revised

December 2, 2024

CC-0050

Monoclonal Antibodies to Interleukin-23

Revised

December 2, 2024

CC-0066

Monoclonal Antibodies to Interleukin-6

Revised

December 2, 2024

CC-0071

Entyvio (vedolizumab)

Revised

December 2, 2024

*CC-0048

Spinraza (nusinersen)

Revised

December 2, 2024

*CC-0003

Immunoglobulins

Revised

December 2, 2024

*CC-0058

Sandostatin and Sandostatin LAR (Octreotide) / Octreotide Agents

Revised

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-069101-24-CPN68761

Policy UpdatesMedicaidNovember 7, 2024

Clinical Criteria update

Effective December 11, 2024

Summary: On May 17, 2024, the Pharmacy and Therapeutic (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem. These policies were developed, revised, or reviewed to support clinical coding edits.

Visit Clinical Criteria to search for specific policies. For questions or additional information, use this email.

Please see the explanation/definition for each category of Clinical Criteria below:

  • New: newly published criteria
  • Revised: addition or removal of medical necessity requirements, new document number
  • Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive

Please share this notice with other providers in your practice and office staff.

Please note:

  • The Clinical Criteria listed below apply only to the medical drug benefits contained within the member’s medical policy. This does not apply to pharmacy services.
  • This notice is meant to inform the provider of new or revised criteria that have been adopted by Anthem only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.

Effective date

Clinical Criteria number

Clinical Criteria title

New or revised

December 11, 2024

*CC-0262

Tevimbra (tislelizumab-jsgr)

New

December 11, 2024

*CC-0162

Tepezza (teprotumumab-trbw)

Revised

December 11, 2024

*CC-0111

Nplate (romiplostim)

Revised

December 11, 2024

CC-0165

Trodelvy (sacituzumab govitecan)

Revised

December 11, 2024

*CC-0002

Colony Stimulating Factor Agents

Revised

December 11, 2024

CC-0128

Tecentriq (atezolizumab)

Revised

December 11, 2024

*CC-0098

Doxorubicin Liposome (Doxil, Lipodox)

Revised

December 11, 2024

*CC-0101

Torisel (temsirolimus)

Revised

December 11, 2024

*CC-0107

Bevacizumab for Non-Ophthalmologic Indications

Revised

December 11, 2024

CC-0143

Polivy (polatuzumab vedotin-piiq)

Revised

December 11, 2024

*CC-0092

Adcetris (brentuximab vedotin)

Revised

December 11, 2024

CC-0106

Erbitux (cetuximab)

Revised

December 11, 2024

*CC-0105

Vectibix (panitumumab)

Revised

December 11, 2024

CC-0145

Libtayo (cemiplimab-rwlc)

Revised

December 11, 2024

CC-0160

Vyepti (eptinezumab)

Revised

December 11, 2024

CC-0102

GNRH Analogs for Oncologic Indications

Revised

December 11, 2024

CC-0201

Rybrevant (amivantamab-ymjw)

Revised

December 11, 2024

*CC-0188

Imcivree (setmelanotide)

Revised

December 11, 2024

*CC-0124

Keytruda (pembrolizumab)

Revised

December 11, 2024

CC-0041

Complement C5 Inhibitors

Revised

December 11, 2024

CC-0199

Empaveli (pegcetacoplan)

Revised

December 11, 2024

*CC-0130

Imfinzi (durvalumab)

Revised

December 11, 2024

CC-0240

Zynyz (retifanlimab-dlwr)

Revised

December 11, 2024

CC-0123

Cyramza (ramucirumab)

Revised

December 11, 2024

CC-0187

Breyanzi (lisocabtagene maraleucel)

Revised

December 11, 2024

CC-0158

Enhertu (fam-trastuzumab deruxtecan-nxki)

Revised

December 11, 2024

CC-0226

Elahere (mirvetuximab)

Revised

December 11, 2024

CC-0043

Monoclonal Antibodies to Interleukin-5

Revised

December 11, 2024

*CC-0066

Monoclonal Antibodies to Interleukin-6

Revised

December 11, 2024

CC-0221

Spevigo (spesolimab-sbzo)

Revised

December 11, 2024

CC-0071

Entyvio (vedolizumab)

Revised

December 11, 2024

*CC-0063

Ustekinumab Agents

Revised

Anthem Blue Cross and Blue Shield Healthcare Solutions is the trade name of Community Care Health Plan of Nevada, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CD-063670-24-CPN63281

Policy UpdatesMedicaidNovember 15, 2024

Clinical Criteria updates

Effective December 18, 2024

Summary:

On August 16, 2024, the Pharmacy and Therapeutic (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem. These policies were developed, revised or reviewed to support clinical coding edits.

Visit Clinical Criteria to search for specific policies. For questions or additional information, use this email.

Please see the explanation/definition for each category of Clinical Criteria below:

  • New: newly published criteria
  • Revised: addition or removal of medical necessity requirements, new document number
  • Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive

Please share this notice with other members of your practice and office staff.

Please note:

  • The Clinical Criteria listed below applies only to the medical drug benefits contained within the member’s medical policy. This does not apply to pharmacy services.
  • This notice is meant to inform the provider of new or revised criteria that has been adopted by Anthem only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice

Effective date

Clinical Criteria number

Clinical Criteria title

New or revised

December 18, 2024

*CC-0266

Rytelo (imetelstat)

New

December 18, 2024

CC-0156

Reblozyl (luspatercept)

Revised

December 18, 2024

CC-0244

Columvi (glofitamab-gxbm)

Revised

December 18, 2024

CC-0124

Keytruda (pembrolizumab)

Revised

December 18, 2024

CC-0104

Levoleucovorin Agents

Revised

December 18, 2024

CC-0182

Iron Agents

Revised

December 18, 2024

CC-0197

Jemperli (dostarlimab-gxly)

Revised

December 18, 2024

CC-0247

Beyfortus (nirsevimab)

Revised

December 18, 2024

*CC-0007

Synagis (palivizumab)

Revised

December 18, 2024

*CC-0082

Onpattro (patisiran)

Revised

December 18, 2024

*CC-0217

Amvuttra (vulrisiran)

Revised

December 18, 2024

*CC-0084

Tegsedi (inotersen)

Revised

December 18, 2024

*CC-0010

Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Inhibitors

Revised

December 18, 2024

CC-0209

Leqvio (inclisiran)

Revised

December 18, 2024

*CC-0193

Evkeeza (evinacumab)

Revised

December 18, 2024

*CC-0027

Denosumab

Revised

December 18, 2024

CC-0019

Zoledronic Acid

Revised

December 18, 2024

CC-0208

Adbry (tralokinumab)

Revised

December 18, 2024

*CC-0029

Dupixent (dupilumab)

Revised

December 18, 2024

*CC-0246

Rystiggo (rozanolixizumab-noli)

Revised

December 18, 2024

*CC-0207

Vyvgart (efgartigimod alfa-fcab) and Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-gvfc)

Revised

December 18, 2024

*CC-0028

Benlysta (belimumab)

Revised

December 18, 2024

*CC-0194

Cabenuva (cabotegravir extended-release; rilpivirine extended -release) injection

Revised

December 18, 2024

*CC-0002

Colony Stimulating Factor Agents

Revised

December 18, 2024

CC-0127

Darzalex (daratumumab) and Darzalex Faspro (daratumumab and hyaluronidase-fihj)

Revised

December 18, 2024

CC-0121

Gazyva (obinutuzumab)

Revised

December 18, 2024

CC-0242

Epkinly (epcoritamab-bysp)

Revised

December 18, 2024

CC-0130

Imfinzi (durvalumab)

Revised

December 18, 2024

CC-0158

Enhertu (fam-trastuzumab deruxtecan-nxki)

Revised

December 18, 2024

CC-0050

Monoclonal Antibodies to Interleukin-23

Revised

December 18, 2024

CC-0066

Monoclonal Antibodies to Interleukin-6

Revised

December 18, 2024

CC-0071

Entyvio (vedolizumab)

Revised

December 18, 2024

*CC-0048

Spinraza (nusinersen)

Revised

December 18, 2024

*CC-0003

Immunoglobulins

Revised

December 18, 2024

*CC-0058

Sandostatin and Sandostatin LAR (Octreotide) / Octreotide Agents

Revised

Anthem Blue Cross and Blue Shield Healthcare Solutions is the trade name of Community Care Health Plan of Nevada, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CD-070787-24-CPN70546

Medical Policy & Clinical GuidelinesMedicaidNovember 14, 2024

Medical Policies and Clinical Utilization Management Guidelines update

Effective December 15, 2024

The Medical Policies, Clinical Utilization Management (UM) Guidelines, and Third-Party Criteria below were developed and/or revised during Quarter Two, 2024. Note, several policies and guidelines were revised to provide clarification only and are not included. Some may have expanded rationales, medical necessity indications, or criteria, and some may involve changes to policy position statements that might result in services that previously were covered being found to be not medically necessary.

Please share this notice with other providers in your practice and office staff.

To view a guideline, visit Provider Medical Policy Search Results | Anthem.com.

Notes/updates

Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive:

  • MED.00055 — Wearable Cardioverter Defibrillators:
    • Reformatted language from the to a wearable cardioverter defibrillator and moved punctuation
    • Added Not Medically Necessary statement when individual has an automated external defibrillator
  • MED.00148 — Gene Therapy for Metachromatic Leukodystrophy:
    • Outlines the Medically Necessary and Not Medically Necessary criteria for gene therapy for metachromatic leukodystrophy
  • RAD.00069 — Absolute Quantitation of Myocardial Blood Flow Measurement:
    • The use of absolute quantitation of myocardial blood flow testing is considered Investigational & Not Medically Necessary for all indications
  • SURG.00011 — Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting:
    • Revised ocular indications, including the addition of SurSight to Medically Necessary and Not Medically Necessary section and added new Medically Necessary criterion addressing non-healing or persistent corneal epithelial defects
    • Removed VersaWrap from Investigational & Not Medically Necessary statement
    • Removed Phasix Mesh from Investigational & Not Medically Necessary statement
    • Added Phasix Mesh and Phasix ST Mesh to Medically Necessary and Not Medically Necessary statements
  • CG-DME-54 — Mechanical Insufflation-Exsufflation Devices:
    • Outlines the Medically Necessary and Not Medically Necessary criteria for use of mechanical insufflation-exsufflation devices

Medical Policies

On May 9, 2024, the Medical Policy and Technology Assessment Committee (MPTAC) approved the following Medical Policies applicable to Anthem. These medical policies take effect December 15, 2024.

Publish Date

Medical Policy Number

Medical Policy Title

New or Revised

6/28/2024

ANC.00009

Cosmetic and Reconstructive Services of the Trunk, Groin, and Extremities

Revised

6/28/2024

*MED.00055

Wearable Cardioverter Defibrillators

Revised

5/16/2024

*MED.00148

Gene Therapy for Metachromatic Leukodystrophy

Revised

6/28/2024

*RAD.00069

Absolute Quantitation of Myocardial Blood Flow Measurement

New

6/28/2024

*SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

Revised

6/28/2024

SURG.00121

Transcatheter Heart Valve Procedures

Revised

Clinical UM Guidelines

On May 9, 2024, the MPTAC approved the following Clinical UM Guidelines applicable to Anthem. These guidelines were adopted by the medical operations committee for Medicaid members on June 27, 2024. These guidelines take effect December 15, 2024.

Publish Date

Clinical UM Guideline Number

Clinical UM Guideline Title

New or Revised

6/28/2024

*CG-DME-54

Mechanical Insufflation-Exsufflation Devices

New

6/28/2024

CG-DME-55

Automated External Defibrillators for Home Use

New

6/28/2024

CG-MED-68

Therapeutic Apheresis

Revised

6/28/2024

CG-MED-97

Biofeedback and Neurofeedback

New

Anthem Blue Cross and Blue Shield Healthcare Solutions is the trade name of Community Care Health Plan of Nevada, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CD-068656-24-CPN68109

Reimbursement PoliciesCommercialDecember 1, 2024

Material adverse change

Reimbursement policy update: Nurse Practitioner and Physician Assistant Services — Professional

Beginning with dates of service on or after March 1, 2025, we will update the Nurse Practitioner and Physician Assistant Services — Professional reimbursement policy as indicated below.

The following services will be removed from the policy and are eligible for a payment reduction when billed by a nurse practitioner (NP) or physician assistant (PA) provider:

  • Preventive Services
  • Radiology Services

The following services will be added to the policy and will not be considered for a payment reduction when billed by a nurse practitioner (NP) or physician assistant (PA) provider:

  • Drugs
  • Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS)
  • Laboratory Services and Laboratory Screening Tests

Under the current reimbursement structure, the NP/PA services will not be reduced in payment, as mentioned above.

 For specific policy details, visit the reimbursement policy page.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CM-072624-24

Reimbursement PoliciesCommercialDecember 1, 2024

Material adverse change

New reimbursement policy: Trauma Activation — Facility

Beginning with dates of service on or after March 1, 2025, Anthem will implement a new reimbursement policy titled Trauma Activation — Facility.

Under this policy, trauma activation services billed on a UB-04 claim form will be considered for reimbursement when the following criteria are met:

  • Revenue code 068X (trauma activation) and CPT® code 99291 (critical care) must be billed on the same claim. The claim will not be considered for reimbursement if submitted without CPT code 99291 billed on the same claim.
  • At least 30 minutes of critical care services must be rendered by the trauma activation team.

For specific policy details, visit the reimbursement policy page.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-072871-24

Products & ProgramsCommercialNovember 21, 2024

Expansion of Carelon Medical Benefits Management, Inc. programs

At a glance:

  • Carelon Medical Benefits Management will expand programs to include cardiovascular, musculoskeletal, and surgical reviews beginning March 1, 2025.
  • Additional outpatient UM will include transportation, fertility, and various other therapeutic and monitoring services.
  • Providers must obtain online pre‑service reviews for certain procedures starting February 24, 2025.

As a reminder, effective March 1, 2025, Carelon Medical Benefits Management will expand multiple programs to perform medical necessity reviews for additional procedures for our members. Carelon Medical Benefits Management works to improve healthcare quality and manage costs for today’s most complex and prevalent tests and treatments, helping promote appropriate, safe, and affordable care.

The continued migration will expand clinical appropriateness reviews for procedures related to the following existing Carelon Medical Benefits Management programs: cardiovascular, musculoskeletal, and surgical. In addition, some codes will migrate into a new Carelon Medical Benefits Management solution — additional outpatient UM that will include some transportation (including ambulance) and fertility procedures, as set forth below. Transportation may include emergency post‑service reviews.

Our Clinical UM Guidelines and Medical Policies (also known as coverage guidelines in Virginia) for medical necessity review are listed in the table below. Carelon Medical Benefits Management will begin accepting prior authorization requests on February 24, 2025, for dates of service on or after March 1, 2025.

Members included in the new program

Updates to Carelon Medical Benefits Management programs apply to select local fully insured members and members covered under self‑insured (ASO) benefit plans with services medically managed by Carelon Medical Benefits Management. This notice does not apply to certain HMO, BlueCard®, Medicare Advantage, Medicaid, Medicare supplemental, or Federal Employee Program® (FEP®) plans. For more information, please contact the phone number on the back of the member ID card. 

Pre‑service review requirements

For procedures scheduled to begin on or after March 1, 2025, all care providers must contact Carelon Medical Benefits Management to obtain a pre‑service review for the services, including, but not limited to, the following non‑emergency modalities. Please refer to the Clinical Guidelines at Anthem.com > Providers > Provider Resources > Policies, Guidelines & Manuals for complete code lists.

Note: All codes will be reviewed for medical necessity for the requested service and not for site of care.

Program

Services

Medical Policies or Clinical Guidelines

Additional outpatient UM

  • Fertility
  • Therapeutic Apharesis
  • Hyperbaric Oxygen Therapy
  • Physiologic Record of Tremor
  • Parenteral Nutrition
  • Imaging Eval. of Skin Lesions
  • Ambulance Services
  • Virtual Reality-Assisted Therapy Systems
  • Quantitative Sensory Test
  • Automated Nerve Conduction
  • Bioimpedance Spectroscopy
  • Autonomic Test
  • Monitor Intraocular Pressure
  • Seizure Monitoring
  • Home Visual Field Monitor
  • Eye Movement Analysis for Dx of Concussion
  • Colonic Irrigation
  • Electrical Stim. Tx. for Pain & Other Conditions
  • Sensory Stim. for Brain Injury
  • Automated Evacuation of Meibomian Gland
  • Selected Sleep Testing

  • CG-MED-68
  • MED.00101
  • CG-MED-89
  • CG-MED-73
  • DME.00011
  • DME.00048
  • MED.00011
  • MED.00082
  • MED.00092
  • MED.00103
  • MED.00105
  • MED.00112
  • MED.00118
  • MED.00130
  • MED.00131
  • MED.00137
  • MED.00141
  • MED.00002
  • MED.00004
  • CG-MED-66
  • CG-MED-88
  • CG-SURG-35
  • LAB.00045
  • CG-ANC-04
  • CG-ANC-06

Cardiovascular

  • Carotid Sinus Baroreceptor Stim. Devices
  • Venous angioplasty w/wo stent placement
  • Vein embolization tx for pelvic congestion syndrome and varicocele
  • Tx of varicose veins
  • Artery stent placement w/wo angioplasty
  • Embolization proc.
    Dialysis circuit proc.
  • CG-SURG-106
  • CG-SURG-119
  • CG-SURG-28
  • CG-SURG-76
  • CG-SURG-83
  • CG-SURG-93
  • RAD.00059
  • SURG.00062
  • SURG.00124

Musculoskeletal

  • Peripheral Nerve Blocks for Tx of Neuropathic PainImplant of Nerve Stim. Devices
  • SURG.00140
  • SURG.00158
  • SURG.00112

Surgical

  • Anesthesia for Dental Svcs.
  • Skin Related Cosmetic & Reconstructive Services
  • Balloon Dilation of Eustachian Tubes
  • Functional Endoscopic Sinus Surgery
  • Bronchial Thermoplasty
  • Balloon Sinus Ostial Dilation
  • Cochlear & Auditory Brainstem Implants
  • Implantable Hearing Aids
  • Surg. Tx for OSA & Snoring
  • Drug-Eluting Devices to Maintain Sinus Ostial Patency
  • Minimally Invasive Tx of Posterior Nasal Nerve for Rhinitis
  • Temporomandibular Disorders
  • Septoplasty
  • Nasal Valve Repair
  • Bariatric Surgery
  • MRI Guided US Ablation for Non-Oncologic Indications
  • Uterine Fibroid Ablation
  • Sacral Nerve Stim. Tx of Neurogenic Bladder secondary to Spinal Cord Injury
  • Vagus Nerve Stim.
  • Ablation for Solid Tumors Outside the Liver
  • Irreversible Electroporation
  • Corneal Collagen Cross Linking
  • Intraocular Telescope
  • Automated Evacuation of Meibomian Gland
  • Correct Intraocular Lenses
  • Viscocanalostomy & Canaloplasty
  • Intraocular Anterior Segment Aqueous Drainage Devices
  • Extracorporeal Shock Wave Therapy
  • Implant of Nerve Stim. Devices
  • Implanted Artificial Iris Devices
  • Implanted Port Delivery Systems for Ocular Disease
  • Implantable Infusion Pumps
  • Tx for Urinary & Fecal Incontinence
  • Reduction Mammaplasty
  • Mastectomy for Gynecomastia
  • Panniculectomy & Abdominoplasty
  • Regenerative Cell Therapy & Soft Tissue Augmentation
  • Products for Wound Healing & Soft Tissue Grafting
  • Surg. & Ablative Tx for Chronic Headaches
  • Intraoperative Assess. of Surgical Margins During Breast-Conserving Surg.
  • Mandibular/Maxillary Surg.
  • Blepharoplasty, Repair & Brow Lift
  • Internal Rib Fixation Systems
  • Prostate Saturation Biopsy
  • Focal Laser Ablation for Tx of Prostate Cancer
  • Penile Prosthesis Implantation
  • Diaphragmatic/Phrenic Nerve Stim. & Pacing Systems
  • US Ablation for Oncologic Indications
  • Radiofrequency Ablation of Renal Sympathetic Nerves
  • Hysterectomy
  • Laparoscopic Gynecologic Surgery
  • Myomectomy
  • Transurethral Destruction, Prostate Tissue
  • Nerve Block Therapy for Tx of Headache & Neuralgia
  • Deep Brain, Cortical, and Cerebellar Stim.
  • SURG.00045
  • SURG.00112
  • SURG.00144
  • SURG.00129
  • ANC.00007
  • CG-MED-41
  • CG-MED-79
  • CG-MED-81
  • CG-SURG-03
  • CG-SURG-08
  • CG-SURG-09
  • CG-SURG-105
  • CG-SURG-117
  • CG-SURG-118
  • CG-SURG-12
  • CG-SURG-120
  • CG-SURG-18
  • CG-SURG-24
  • CG-SURG-61
  • CG-SURG-71
  • CG-SURG-73
  • CG-SURG-79
  • CG-SURG-81
  • CG-SURG-82
  • CG-SURG-83
  • CG-SURG-84
  • CG-SURG-88
  • CG-SURG-95
  • CG-SURG-96
  • CG-SURG-99MCG: ISC: S-660/660-RRG: Hysterectomy, Vaginal
  • MCG: ISC: S-450/450-RRG/5450: Laparotomy for Gynecologic Surgery, Including Myomectomy, Oophorectomy, and Salpingectomy
  • MCG: ISC: S-660/660-RRG: Hysterectomy, Vaginal
  • MCG: ISC: S-665/665-RRG: Hysterectomy, Laparoscopic
  • MCG: ISC: S-775/775-RRG: Laparoscopic Gynecologic Surgery, Including Myomectomy, Oophorectomy, and Salpingectomy
  • MED.00057
  • MED.00103
  • MED.00132
  • SURG.00010
  • SURG.00011
  • SURG.00061
  • SURG.00077
  • SURG.00079
  • SURG.00084
  • SURG.00095
  • SURG.00096
  • SURG.00107
  • SURG.00118
  • SURG.00120
  • SURG.00126
  • SURG.00132
  • SURG.00135
  • SURG.00139
  • SURG.00156
  • SURG.00157
  • SURG.00159
  • SURG.00160
  • SURG.00026

To determine if prior authorization is needed for a member on or after March 1, 2025, contact the Provider Services phone number on the back of the member’s ID card for benefit information. Care providers using the Interactive Care Reviewer (ICR) tool on http://Availity.com/ to pre‑certify an outpatient procedure will receive a message referring the provider to Carelon Medical Benefits Management. (Note: ICR cannot accept prior authorization requests for services administered by Carelon Medical Benefits Management.)

Care providers should continue to submit pre‑service review requests to Carelon Medical Benefits Management using the convenient online service provided on the Carelon Medical Benefits Management provider website. The website is available 24 hours a day, seven days a week, and processes requests in real time using Clinical Criteria. Go to https://www.providerportal.com/ to register.

For more information

For resources to help your practice get started with the cardiology, musculoskeletal, radiology, sleep, surgical procedures, and radiation oncology programs, visit:

Cardiovascular Solution | Carelon Insights

Radiology Solution | Carelon Insights

Sleep Solution | Sleep Healthcare | Carelon Insights

Surgical Procedures Solution | Carelon Insights

Radiation Oncology Solution | Carelon Insights

Additional Outpatient Utilization Management

Sign up at provider training for provider training for the additional outpatient UM:

  • Wednesday, February 5, 2025, at 12 p.m. ET/11 a.m. CT
  • Wednesday, February 12, 2025, at 12 p.m. ET/11 a.m. CT
  • Friday, February 21, 2025, at 11 a.m. ET/10 a.m. CT
  • Wednesday, February 26, 2025, at 12 p.m. ET/11 a.m. CT
  • Wednesday, March 5, 2025, at 12 p.m. ET/11 a.m. CT

Our website, Anthem.com, provides information and tools such as order entry checklists, Clinical Guidelines, and FAQ. You can also contact your provider relationship management representative if you have any questions.

Through genuine collaboration, we can simplify access to care and help you deliver high‑quality, equitable healthcare.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-072839-24

Federal Employee Program (FEP)CommercialDecember 1, 2024

FEP excited to join PSHB program in 2025

What’s changing

Effective January 1, 2025, postal employees will break out of the current Blue Cross Blue Shield Service Benefit Plan structure and participate in their own health benefit program: Postal Service Health Benefit Program (PSHB).

Refer to the attachment for more information.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-072405-24

ATTACHMENTS (available on web): FEP excited to join PSHB program in 2025 (pdf - 0.2mb)

PharmacyCommercialNovember 18, 2024

Material adverse change

Specialty pharmacy updates — December 2024

Specialty pharmacy updates for Anthem are listed below.

Prior authorization clinical review of non-oncology use of specialty pharmacy drugs is managed by Anthem’s medical specialty drug review team. Review of specialty pharmacy drugs for oncology use is managed by Carelon Medical Benefits Management, Inc., a separate company.

Note: Currently, your patients may be receiving these medications without prior authorization. As of the effective date below, you may be required to request prior authorization review for your patients’ continued use of these medications.

Prior authorization updates

Effective for dates of service on or after March 1, 2025, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our prior authorization review process.

Access our Clinical Criteria to view the complete information for these prior authorization updates.

Clinical Criteria

Drug

HCPCS or CPT® code(s)

CC-0267

Ebglyss (lebrikizumab-lbkz)

C9399, J3590

CC-0072

Eylea (aflibercept) biosimilars:

Ahzantive (aflibercept-mrbb)
Enzeevu (aflibercept-abzv)
Opuviz (aflibercept-yszy)
Pavblu (aflibercept-ayyh)
Yesafili (aflibercept-jbvf)

C9399, J3590

CC-0268*

Lymphir (denileukin diftitox-cxdl)

C9399, J9999

CC-0269

Nemluvio (nemolizumab-ilto)

C9399, J3590

CC-0270*

Niktimvo (axatilmab-csfr)

C9399, J3590

CC-0011

Ocrevus Zunovo (ocrelizumab/hyaluronidase-ocsq)

J3590

CC-0271

Tecelra (afamitresgene autoleucel)

C9399, J9999

* Oncology use is managed by Carelon Medical Benefits Management.

Note: Prior authorization requests for certain medications may require additional documentation to determine medical necessity.

Step therapy updates

Effective for dates of service on or after March 1, 2025, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our existing specialty pharmacy medical step therapy review process.

Access our Clinical Criteria to view the complete information for these step therapy updates.

Clinical Criteria

Status

Drug

HCPCS or CPT code(s)

CC-0011

Non-preferred

Ocrevus Zunovo (ocrelizumab/hyaluronidase-ocsq)

J3590

Quantity limit updates

Effective for dates of service on or after March 1, 2025, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our quantity limit review process.

Access our Clinical Criteria to view the complete information for these quantity limit updates.

Clinical Criteria

Drug

HCPCS or CPT code(s)

CC-0267

Ebglyss (lebrikizumab-lbkz)

C9399, J3590

CC-0072

Eylea (aflibercept) biosimilars:

Ahzantive (aflibercept-mrbb)
Enzeevu (aflibercept-abzv)
Opuviz (aflibercept-yszy)
Pavblu (aflibercept-ayyh)
Yesafili (aflibercept-jbvf)

C9399, J3590

CC-0269

Nemluvio (nemolizumab-ilto)

C9399, J3590

CC-0011

Ocrevus Zunovo (ocrelizumab/hyaluronidase-ocsq)

J3590

Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-072458-24-CPN72383

PharmacyCommercialDecember 1, 2024

Pharmacy information available online

Visit the Drug Lists page here for more information on:

  • Copayment/coinsurance requirements and their applicable drug classes
  • Drug lists and changes
  • Prior authorization criteria
  • Procedures for generic substitution
  • Therapeutic interchange
  • Step therapy or other management methods subject to prescribing decisions
  • Any other requirements, restrictions, or limitations that apply to using certain drugs

The Commercial and Exchange drug lists are posted to the website quarterly on the first day of the month in January, April, July, and October.

To locate Exchange Select Formulary and pharmacy information, scroll down to Select Drug Lists. This drug list is also reviewed and updated regularly as needed.

FEP Pharmacy updates and other pharmacy-related information may be accessed at https://www.fepblue.org/ under Pharmacy.

If you do not have internet access, please call Provider Services to request a copy of the pharmaceutical information available online.

Through our efforts, we can help our care provider partners deliver high-quality, equitable healthcare.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-072066-24-CPN70341

PharmacyCommercialDecember 1, 2024

Kroger Specialty Pharmacy acquisition

The parent company of our pharmacy benefit management partner, CarelonRx, Inc., has acquired Kroger Specialty Pharmacy. This follows the recent acquisitions of Paragon Healthcare, Inc. and BioPlus Specialty Pharmacy, all aimed at enhancing support for individuals with chronic and complex conditions.

To ensure a seamless patient experience, most prescriptions for former Kroger Specialty Pharmacy patients are being handled by BioPlus Specialty Pharmacy, a CarelonRx company. This acquisition supports the ability of BioPlus to provide a comprehensive and personalized experience focused on the patient’s whole health. If you have new specialty pharmacy prescriptions, please send them to BioPlus Specialty Pharmacy.

If you have any questions, please call your Anthem provider relationship management representative.

CarelonRx, Inc. is an independent company providing pharmacy benefit management services on behalf of the health plan.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-072450-24-CPN72371

PharmacyCommercialDecember 1, 2024

Paragon Healthcare joins our medical specialty pharmacy provider network in 2025

On January 1, 2025, Paragon Healthcare will join our medical specialty pharmacy provider network, for drugs covered under your patients’ medical benefit. For more than 20 years, Paragon Healthcare has specialized in providing life-saving and life-giving infusible and injectable drug therapies through their omnichannel model of ambulatory infusion centers, home infusion pharmacies, and other specialty pharmacy services.

What happens next?

You may begin sending new prescriptions or renewals for medical specialty medications to a Paragon Healthcare specialty pharmacy, beginning January 1, 2025. You can reach Paragon Specialty at:

  • Phone: 866-906-6560
  • Fax: 833-329-4343
  • NPI: 1114058534

Later in 2025, eligible medical specialty prescriptions with open refills at CVS Specialty Pharmacy will start to be transferred to Paragon Healthcare. You will receive a letter in the mail prior to each wave of migration with more details. Impacted patients will also receive a letter and phone call explaining the transition before it happens.

If you have questions, please call your provider relationship management representative. We are committed to finding solutions that help you offer quality services to your patients.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-072448-24-CPN72367

PharmacyMedicare AdvantageNovember 14, 2024

Medicare Part D overhaul: What's new in 2025 for your prescription drug costs?

At a glance:

  • Significant Medicare Part D updates in 2025 include a $2,000 out-of-pocket cap and elimination of the coverage gap.
  • Enhanced benefits will remove cost-sharing in catastrophic coverage and expand low-income subsidies to 150% of the federal poverty level (FPL).
  • The Medicare Prescription Payment Plan (M3P) will allow members to spread out prescription costs over the year for added financial flexibility.

What's changing in 2025?

Changes in deductible and out-of-pocket thresholds

In 2024, the standard deductible was $545 with the initial coverage limit at $5,030, and the catastrophic coverage threshold was $8,000. By 2025, the deductible will increase to $590, and members will enter the catastrophic phase when their out-of-pocket expenditure reaches $2,000. Members might see higher upfront costs due to the increased deductible, but reaching catastrophic coverage will be significantly easier, offering greater financial protections much sooner.

Elimination of the coverage gap (donut hole)

The elimination of the coverage gap will simplify the benefit structure. Previously, beneficiaries paid 25% of the cost of both brand-name and generic drugs in the coverage gap. The full elimination of this gap will remove the phase where members faced higher out-of-pocket costs, reducing financial uncertainty and streamlining the benefits process.

Introduction of a $2,000 out-of-pocket cap

In 2025, after reaching the $2,000 out-of-pocket cap, members will no longer have to pay added costs for their medications for the remainder of the year. This offers financial protection and predictability in managing healthcare expenses, helping those with high prescription drug costs.

Elimination of cost-sharing in catastrophic coverage

In 2024, members had to pay 5% of drug costs after reaching the out-of-pocket threshold; this requirement will lift entirely in the next year. This ensures complete coverage once members reach the catastrophic phase, removing the financial burden for members with extremely high drug costs.

Enhanced low-income subsidy (LIS) benefits

We are also introducing enhanced LIS benefits, extending full benefits to individuals with incomes up to 150% of the FPL from the previous 135% FPL threshold. This change means more members will qualify for full LIS benefits, reducing their premiums, deductibles, and copayments, which improves access to necessary medications for low-income beneficiaries.

Introduction of the Medicare Prescription Payment Plan (M3P)

M3P allows members to manage their out-of-pocket Medicare Part D drug costs by spreading the total sum of their filled prescription costs across the calendar year. This option is voluntary, free to enroll, and members can choose to participate at any point during the year. Instead of paying at the pharmacy, members will receive a bill from their health or drug plan to pay for their prescription drugs each month, offering greater financial flexibility and predictability.

Navigating 2025 formulary changes: leveraging your EMR prescription drug price transparency tool

With Real-Time Prescription Benefit (RTPB), providers can access patient-specific drug benefit information within the e-prescribing process in their electronic health record (EHR). This functionality allows providers to proactively identify formulary medications, barriers to cost and improve medication adherence.

How Real-Time Prescription Benefit works:

  1. Prescriber enters prescription information through e-prescribing.
  2. The e-prescribing system triggers a data call to the pharmacy benefit manager (PBM)
  3. The PBM receives real-time prescription benefit request
  4. The PBM delivers cost, formulary, and utilization information for the selected pharmacy back to the prescriber’s EHR.
  5. Prescriber and patient make a choice together.
  6. Help your patients navigate the 2025 formulary changes and save money on their prescriptions with Real-Time Prescription Benefit. Find out if your EHR vendor provides Real-Time Prescription Benefit. There’s no charge for the service; however, you will need the latest version of your EHR.

Action plan and resources

To ensure a smooth transition, we’ve laid out a comprehensive educational and communication strategy:

  • Information campaign: As of July 2024, we began an extensive marketing and educational campaign, including public relations efforts, direct member communications, and care provider briefings.
  • Training and support: We are providing training materials, talking points, and FAQs to our support teams, ensuring they are well-prepared to assist you.

Key dates:

  • October 15, 2024: Enrollment in M3P begins.
  • January 1, 2025: All other M3P requirements become effective.

Next steps:

  • Care providers should stay up to date and make use of the resources we provide to better assist patients. Staying updated on any changes in the formulary and benefit structures will ensure that you can provide the highest quality care possible.
  • Members should keep an eye out for detailed communications about their enhanced Medicare Part D coverage. Members can contact our support team for personalized assistance.

Contact us

Availity Chat with Payer is available during normal business hours. Get answers to your questions about eligibility, benefits, authorizations, claims status, and more. To access Availity Essentials, go to https://Availity.com and select the appropriate payer space tile from the drop-down. Then, select Chat with Payer and complete the pre-chat form to start your chat.

For additional support, visit the Contact Us section of our provider website for the appropriate contact.

As we move into 2025, our goal is to provide you with the knowledge and resources needed to maximize the new Medicare Part D benefits. Thank you for trusting us to help manage your healthcare needs.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-072216-24-CPN72003